Table of contents
November 2013 - Volume 1 - Suppl 1
Abstracts of the 28th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)
Oral Presentation
- Uncovering a novel function of BTLA on tumor-infiltrating CD8+ T cells (7 November, 2013)
Poster Presentation
- Bioengineering cytotoxic T cells to target opportunistic fungal infection (7 November, 2013)
- Pre-T cell receptor for improved expansion of TCR alpha disrupted T cells (7 November, 2013)
- Improved affinity AFP-specific T cell receptor for hepatocellular carcinoma (7 November, 2013)
- Augmenting adoptive T cell therapy through universal chimeric costimulators (7 November, 2013)
- The role of transcription factor Runx2 in tumor infiltrating T cells (7 November, 2013)
- Quantitative single-cell characterization of CAR+ T cell effector functions (7 November, 2013)
- ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy (7 November, 2013)
- Targeting MICA with therapeutic antibodies for the treatment of cancer (7 November, 2013)
- TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells (7 November, 2013)
- Genomic scale analysis of NK cells impact on response to IFN-α (7 November, 2013)
- SSX expression and function in prostate cancer (7 November, 2013)
- Programmed death-ligand 1 (PD-L1) expression in various tumor types (7 November, 2013)
- Direct analysis of HLA/HER-2 peptide epitopes (7 November, 2013)
- Cyclophosphamide mechanism of action in preclinical tecemotide studies (7 November, 2013)
- Cancer therapy by restoration of immune Notch (7 November, 2013)
- Precision analysis of a whole blood T cell subset immunophenotyping assay (7 November, 2013)
- ELISPOTs produced by CD8 and CD4 cells follow log normal size distribution (7 November, 2013)
- Immunologic hierarchy and promiscuity of melanoma helper peptides (7 November, 2013)
- How frequently are predicted peptides actually recognized by CD8 cells? (7 November, 2013)
- The abscopal effect of local radiotherapy is induced by TGFβ blockade (7 November, 2013)
- Immune consequences of CT-guided radiation therapy of mouse mammary tumors (7 November, 2013)
- The impact of metabolic stress on anti-tumor immunity in laboratory mice (7 November, 2013)
- NK cell HMGB1 mediates IL-2-induced “systemic autophagic” toxicity (7 November, 2013)
- Interferon (IFNγ) induces cell cycle arrest in RCC cell lines (7 November, 2013)
- Targeted tumor therapy: turning the genome on its head (7 November, 2013)
- Intratumoral immunotherapy with the TLR7/8 agonist 3M-052 (7 November, 2013)
- What transposable elements are differentially translated in lung cancer? (7 November, 2013)
- NGS technology applied to melanoma cell lines (7 November, 2013)
- Tumor-associated T cell receptor repertoires in low- and high-grade gliomas (7 November, 2013)
- Siglec-7/-9 ligands shield tumor cells from NK cell attack (7 November, 2013)
- CD8α+ dendritic cells dictate immune responses against murine AML (7 November, 2013)
- Tumor derived exosome induction of the CD3+CD8+ T cell tolerogenic phenotype (7 November, 2013)
- Expression of neuropilin-1 on in vivo induced regulatory T cells (7 November, 2013)
- HLA-G-specific microRNAs a novel approach for targeting tumors (7 November, 2013)
- miR-138 exerts anti-glioma efficacy by targeting immune checkpoints (7 November, 2013)
- Immunotherapy targeting esophageal cancer stem cells (7 November, 2013)
- Tumor monocyte cross talk promotes lymphoma cell resistance to chemotherapy (7 November, 2013)
- Interleukin-8 drives epithelial-mesenchymal transition of human carcinomas (7 November, 2013)
- New equipment optimized for emulsified vaccine prepation in the hospital (7 November, 2013)
- B lymphocyte mediated antigen presentation of plasmid DNA (7 November, 2013)
- Immunogenicity of a lambda phage-based anti-cancer vaccine targeting HAAH (7 November, 2013)
- Development of mutome-specific personalized vaccines for pancreatic cancer (7 November, 2013)
- Targeting hematologic malignancies with oncolytic vaccinia virus constructs (7 November, 2013)
- The impact of age on a mitoxantrone-based tumor vaccine (7 November, 2013)
- Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo (7 November, 2013)
- The effect of chemotherapeutic drugs on human B lymphocytes (7 November, 2013)
- An efficient way to analyze function of immune cells (7 November, 2013)
- Overcoming immune-cell unresponsiveness in cancer (7 November, 2013)
- Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy (7 November, 2013)